Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots

Haemophilia. 2021 Jul;27(4):e487-e490. doi: 10.1111/hae.14199. Epub 2020 Nov 20.

Authors

Stéphanie Désage¹, Valérie Chamouard¹, Sandrine Meunier¹, Nathalie Enjolras², Frédéric Sobas³, Claude Négrier^{1

2

3}, Sandra Le Quellec^{1

2

3}

Affiliations

¹ Unité d'hémostase clinique, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France.
² EA 4609 Hémostase et cancer, Université Claude Bernard Lyon 1, Lyon, France.
³ Service d'hématologie biologique, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Lyon, France.

PMID: 33215792
DOI: 10.1111/hae.14199

No abstract available

Keywords: eptacog alfa; factor VII deficiency; prophylaxis; rFVIIa; sub-dural haematoma.

Publication types

Letter

MeSH terms

Blood Coagulation Disorders*
Factor VII
Factor VII Deficiency* / complications
Factor VII Deficiency* / drug therapy
Factor VIIa / therapeutic use
Humans
Infant, Newborn
Intracranial Hemorrhages / drug therapy
Recombinant Proteins

Substances

Recombinant Proteins
Factor VII
recombinant FVIIa
Factor VIIa